
Canon Unveils New RF75-300m F4-5.6 Telephoto Lens and EOS R100 Kit to Spur Amazing Long-Range Content for Entry-Level Users
Melville, NY, July 09, 2025 (GLOBE NEWSWIRE) — Canon U.S.A., Inc., a leader in digital imaging solutions, has announced the new RF75-300mm F4-5.6 lens, an affordable ultra-telephoto zoom lens that can empower entry-level users to capture standout shots. Also announced today is the EOS R100 Double Zoom Lens Kit, a dynamic package featuring the new RF75-300mm F4-5.6 lens and Canon's EOS R100 hybrid camera, which come together to provide an unbeatable kit for entry-level users.
The RF75-300mm F4-5.6 lens is a lightweight telephoto zoom lens that gives entry-level users the ability to experiment with different focal ranges – shooting up to lengths of 480 mm (35 mm equivalent). Telephoto lenses take shooting to the next level, surpassing the range that can be achieved solely with smartphones. For this class of users, the RF75-300mm F4-5.6 lens, coupled with Canon's EOS R100 or other EOS R series cameras, can enable a greater range of expression and possibilities for shooting sports, landscapes, concerts and live events, and much more.
The Canon EOS R100 camera is Canon's most affordable, compact, and lightweight EOS R camera ever. Designed for new, first-time mirrorless camera or existing interchangeable camera users who previously enjoyed EOS Rebel or EOS M cameras, these users will enjoy that the power of lens selection grants as an advantage over using a smartphone camera. The camera touts key features such as a 24.2 megapixel APS-C size sensor, the DIGIC 8 image processor, 4K (Cropped) and Full HD (Full-Width) video at up to 24 and 60 frames-per-second respectively, Autofocus with eye and face detection, and Bluetooth™ and Wi-Fi® connectivity capabilities.
Pricing and Availability
The RF75-300mm F4-5.6 lens is currently scheduled to be available in July 2025 for the price of $219.99*. The Canon EOS R100 Double Zoom Lens Kit with the new RF75-300mm F4-5.6 lens is currently scheduled to be available in July 2025 for $799.99*. For additional information, please visit www.usa.canon.com.
About Canon U.S.A., Inc.
Canon U.S.A., Inc. is a leading provider of consumer, business-to-business, and industrial digital imaging solutions to the United States and to Latin America and the Caribbean markets. With approximately $29.4 billion in global revenue, its parent company, Canon Inc., as of 2023 has ranked in the top-five overall in U.S. patents granted for 38 consecutive years. † Canon U.S.A. is dedicated to its Kyosei philosophy of social and environmental responsibility. To learn more about Canon, visit us at www.usa.canon.com and connect with us on LinkedIn at https://www.linkedin.com/company/canonusa.
# # #
* Specifications, availability and prices are subject to change without notice. Actual prices are set by individual dealers and may vary.
† Based on weekly patent counts issued by United States Patent and Trademark Office.
Attachment Canon Unveils New RF75-300m F4-5.6 Telephoto Lens
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
an hour ago
- Business Wire
Avidia Bancorp, Inc. Reports Second Quarter 2025 Financial Results
HUDSON, Mass.--(BUSINESS WIRE)--Avidia Bancorp, Inc. (the 'Company') (NYSE: 'AVBC'), the holding company of Avidia Bank, today reported second quarter financial results of Assabet Valley Bancorp, the former mutual holding company of Avidia Bank. As previously reported, Assabet Valley Bancorp completed its mutual-to-stock conversion transaction effective July 31, 2025, which resulted in the Company completing its initial public offering of shares of its common stock and becoming the stock holding company of Avidia Bank. Selected Financial Highlights for the Second Quarter of 2025 Statement of Operations: Quarterly net income was $3.9 million, compared to a net loss of $11.6 million for the first quarter. Quarterly net interest income increased by $1.4 million from the first quarter to $20.6 million. Net interest margin increased by 15 basis points from the first quarter to 3.19%. The cost of interest-bearing liabilities decreased by 13 basis points. The cost of total deposits fell 14 basis points to 1.36%. Provision for credit losses totaled $1.1 million. Quarterly non-interest income increased by $1.5 million from the first quarter to $5.2 million. Quarterly non-interest expense decreased by $2.1 million from the first quarter to $19.8 million. Salaries and employee benefits decreased $2.7 million from the first quarter as there were incentive plan terminations and increased short-term incentive payouts in the previous quarter. The efficiency ratio was 76.4%, compared to 95.2% in the first quarter. Income tax expense was $1.2 million. Balance Sheet: Total cash and cash equivalents increased by $225 million from the first quarter, primarily related to the funds received from the IPO subscription offering. Gross loans increased by $15.0 million from the first quarter to $2.25 billion. Deposits increased by $309 million from the first quarter to $2.44 billion, also primarily related to funds received from the IPO subscription offering. Federal Home Loan Bank advances decreased by $65 million from the first quarter to $260.0 million. Total capital increased by $5.4 million from the first quarter to $191.4 million. Asset Quality: Non-accrual loans to total loans was 0.50% compared to 0.53% in the first quarter. About Avidia Bancorp, Inc. Avidia Bancorp, Inc. is the bank holding company of Avidia Bank. Avidia Bank is a Massachusetts-chartered stock savings bank. With headquarters in Hudson, Massachusetts, it also operates nine full-service banking offices in western Middlesex County and eastern Worcester County, in Massachusetts. Forward-Looking Statements Statements contained in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You can identify forward-looking statements by use of the words "believe," "expect," "anticipate," "intend," "estimate," "assume," "outlook," "will," "should," and other similar expressions which do not relate to historical matters. Although we believe that these forward-looking statements are based on reasonable estimates and assumptions, they are not guarantees of future performance. You should not place undue reliance on forward-looking statements because they are subject to significant risks, uncertainties and other factors which are, in some cases, beyond our control. Our actual results could differ materially from those presented in the forward-looking statements as a result of, among other factors, changes in general business and economic conditions nationwide and in our local markets, including changes which adversely affect borrowers' ability to service and repay loans; changes in customer behavior due to political, business and economic conditions, including inflation; conditions in the capital and debt markets; reductions in net interest income resulting from interest rate volatility and changes in the balances and mix of our loans and deposits; changes in market interest rates and real estate values; decreases in the value of securities and other assets or in deposit levels necessitating increased borrowing to fund loans and investments; competition from other financial institutions; changes in legislation or regulation and accounting principles, policies and guidelines; cybersecurity incidents; fraud; natural disasters; the risk that we may be unsuccessful in implementing our business strategy; and the other risks and uncertainties disclosed in Avidia Bancorp, Inc.'s definitive prospectus dated May 13, 2025, as filed the U.S. Securities and Exchange Commission. Forward looking statements speak only as of the date of this release, and we do not undertake any obligation to update or revise any of them to reflect events or circumstances occurring after the date of this release or to reflect the occurrence of unanticipated events, except as may be required by applicable law or regulation. Assabet Valley Bancorp Consolidated Balance Sheets (Unaudited) As of June 30, 2025 Change From (In thousands) June 30, 2025 March 31, 2025 June 30, 2024 March 31, 2025 June 30, 2024 Assets Cash and due from banks $ 24,667 $ 24,282 $ 15,394 $ 385 1.6 % $ 9,273 60.2 % Short-term investments 283,919 58,800 58,671 225,119 382.9 225,248 383.9 Total cash and cash equivalents 308,586 83,082 74,065 225,504 271.4 234,521 316.6 Securities available for sale, at fair value 266,249 261,946 274,900 4,303 1.6 (8,651 ) (3.1 ) Equity securities, at fair value - - 13,430 - - (13,430 ) (100.0 ) Securities held to maturity, at amortized cost 16,747 16,746 16,746 1 - 1 - Total securities 282,996 278,692 305,076 4,304 - (22,080 ) - Federal Home Loan Bank stock, at cost 12,083 14,729 16,210 (2,646 ) (18.0 ) (4,127 ) (25.5 ) Loans held for sale - 711 1,485 (711 ) (100.0 ) (1,485 ) (100.0 ) Total loans 2,248,021 2,233,033 2,145,471 14,988 0.7 102,550 4.8 Less: Allowance for credit losses (23,425 ) (21,849 ) (20,875 ) (1,576 ) 7.2 (2,550 ) 12.2 Net loans 2,224,596 2,211,184 2,124,596 13,412 0.6 100,000 4.7 Premises and equipment, net 29,098 29,020 28,133 78 0.3 965 3.4 Bank-owned life insurance 36,093 35,805 35,004 288 0.8 1,089 3.1 Accrued interest receivable 8,922 8,802 9,110 120 1.4 (188 ) (2.1 ) Net deferred tax asset 11,323 11,738 14,520 (415 ) (3.5 ) (3,197 ) (22.0 ) Goodwill 11,936 11,936 11,936 - - - - Mortgage servicing rights 3,253 3,289 3,483 (36 ) (1.1 ) (230 ) (6.6 ) Other assets 29,022 17,643 28,700 11,379 64.5 322 1.1 Total Assets $ 2,957,908 $ 2,706,631 $ 2,652,318 $ 251,277 9.3 % $ 305,590 11.5 % Liabilities Deposits $ 2,439,608 $ 2,131,068 $ 2,021,839 $ 308,540 14.5 % $ 417,769 20.7 % Federal Home Loan Bank advances 260,000 325,000 372,300 (65,000 ) (20.0 ) (112,300 ) (30.2 ) Subordinated debt 27,738 27,715 27,605 23 0.1 133 0.5 Mortgagors' escrow accounts 3,498 3,763 3,042 (265 ) (7.0 ) 456 15.0 Accrued expenses and other liabilities 35,638 33,028 40,487 2,610 7.9 (4,849 ) (12.0 ) Total liabilities $ 2,766,482 $ 2,520,574 $ 2,465,273 $ 245,908 9.8 % $ 301,209 12.2 % Capital: Retained earnings $ 207,555 $ 203,683 $ 209,682 $ 3,872 1.9 % $ (2,127 ) (1.0 ) % Accumulated other comprehensive loss (16,129 ) (17,626 ) (22,637 ) 1,497 (8.5 ) 6,508 (28.7 ) Total capital $ 191,426 $ 186,057 $ 187,045 $ 5,369 2.9 $ 4,381 2.3 % Total Liabilities and Capital $ 2,957,908 $ $ 2,652,318 $ 251,277 9.3 % $ 305,590 11.5 % Expand Assabet Valley Bancorp Consolidated Statements of Operations QTD (Unaudited) Three Months Ended June 30, 2025 Change Three Months Ended From Three Months Ended (In thousands) June 30, 2025 March 31, 2025 June 30, 2024 March 31, 2025 June 30, 2024 Interest and dividend income: Loans, including fees $ 28,883 $ 28,183 $ 27,492 $ 700 2.5 % $ 1,391 5.1 % Securities 2,555 2,651 2,833 (96 ) (3.6 ) (278 ) (9.8 ) Other 421 215 568 206 95.8 (147 ) (25.9 ) Total interest and dividend income 31,859 31,049 30,893 810 2.6 966 3.1 Interest expense: Deposits 7,242 7,731 8,285 (489 ) (6.3 ) (1,043 ) (12.6 ) Federal Home Loan Bank advances 3,647 3,792 3,985 (145 ) (3.8 ) (338 ) (8.5 ) Subordinated debt 352 315 315 37 11.7 37 11.7 Total interest expense 11,241 11,838 12,585 (597 ) (5.0 ) (1,344 ) (10.7 ) Net interest income: 20,618 19,211 18,308 1,407 7.3 2,310 12.6 Provision expense (reversal) for credit losses 1,071 17,616 (320 ) (16,545 ) (93.9 ) 1,391 (434.7 ) Net interest income, after provision expense (reversal) for credit losses 19,547 1,595 18,628 17,952 1125.5 919 4.9 Non-interest income: Customer service fees 884 901 762 (17 ) (1.9 ) 122 16.0 Net (loss) on sale of securities available for sale (78 ) (541 ) (1,366 ) 463 (85.6 ) 1,288 (94.3 ) Net recognized gain on equity securities - - 273 - - (273 ) (100.0 ) Net write down on premises and equipment no longer in use - (356 ) - 356 (100.0 ) - - Payment processing income 2,079 2,192 1,798 (113 ) (5.2 ) 281 15.6 Income on bank-owned life insurance 289 279 195 10 3.6 94 48.2 Mortgage banking income 162 16 408 146 912.5 (246 ) (60.3 ) Investment commissions 312 350 352 (38 ) (10.9 ) (40 ) (11.4 ) Debit card income 793 525 573 268 51.0 220 38.4 Credit card income 58 49 335 9 18.4 (277 ) (82.7 ) Other 747 312 115 435 139.4 632 549.6 Total non-interest income 5,246 3,727 3,445 1,519 40.8 1,801 52.3 Non-interest expense: Salaries and employee benefits 8,909 11,566 8,701 (2,657 ) (23.0 ) 208 2.4 Occupancy and equipment 2,042 2,018 2,384 24 1.2 (342 ) (14.3 ) Data processing 2,994 3,378 2,218 (384 ) (11.4 ) 776 35.0 Professional fees 1,088 661 739 427 64.6 349 47.2 Payment processing 932 1,043 992 (111 ) (10.6 ) (60 ) (6.0 ) Deposit insurance 780 632 687 148 23.4 93 13.5 Advertising 310 265 334 45 17.0 (24 ) (7.2 ) Telecommunications 96 92 101 4 4.3 (5 ) (5.0 ) Problem loan and foreclosed real estate, net 194 112 100 82 73.2 94 94.0 Other general and administrative 2,418 2,064 2,707 354 17.2 (289 ) (10.7 ) Total non-interest expense 19,763 21,831 18,963 (2,068 ) (9.5 ) 800 4.2 Income (loss) before income tax expense 5,030 (16,509 ) 3,110 21,539 (130.5 ) 1,920 61.7 Income tax expense (benefit) 1,158 (4,922 ) 759 6,080 (123.5 ) 399 52.6 Net income (loss) $ 3,872 $ (11,587 ) $ 2,351 $ 15,459 (133.4 ) % $ 1,521 64.7 % Expand Assabet Valley Bancorp Consolidated Statements of Operations YTD (Unaudited) Six Months Ended Six Months Ended June 30, 2025 Change (In thousands) June 30, 2025 June 30, 2024 From Six Months Ended June 30, 2024 Interest and dividend income: Loans, including fees $ 57,067 $ 54,750 $ 2,317 4.2 % Securities 5,206 4,953 253 5.1 Other 636 1,038 (402 ) (38.7 ) Total interest and dividend income 62,909 60,741 2,168 3.6 Interest expense: Deposits 14,973 15,872 (899 ) (5.7 ) Federal Home Loan Bank advances 7,439 8,344 (905 ) (10.8 ) Subordinated debt 667 630 37 5.9 Total interest expense 23,079 24,846 (1,767 ) (7.1 ) Net interest income: 39,830 35,895 3,935 11.0 Provision expense (reversal) for credit losses 18,687 310 18,377 5,928.1 Net interest income, after provision expense for credit losses 21,143 35,585 (14,442 ) (40.6 ) Non-interest income: Customer service fees 1,785 1,620 165 10.2 Net (loss) on sale of securities available for sale (619 ) (1,366 ) 747 (54.7 ) Net recognized gain on equity securities - 1,637 (1,637 ) (100.0 ) Net write down on premises and equipment no longer in use (356 ) - (356 ) (100.0 ) Payment processing income 4,271 3,660 611 16.7 Income on bank-owned life insurance 568 407 161 39.6 Mortgage banking income 178 858 (680 ) (79.3 ) Investment commissions 662 660 2 - Debit card income 1,318 1,109 209 18.8 Credit card income 107 566 (459 ) (81.1 ) Other 1,060 193 867 449.2 Total non-interest income 8,974 9,344 (370 ) (4.0 ) Non-interest expense: Salaries and employee benefits 20,475 17,308 3,167 18.3 Occupancy and equipment 4,060 4,468 (408 ) (9.1 ) Data processing 6,372 4,423 1,949 44.1 Professional fees 1,749 1,254 495 39.5 Payment processing 1,975 2,012 (37 ) (1.8 ) Deposit insurance 1,412 1,396 16 1.1 Advertising 575 779 (204 ) (26.2 ) Telecommunications 188 205 (17 ) (8.3 ) Problem loan and foreclosed real estate, net 306 184 122 66.3 Other general and administrative 4,484 5,031 (547 ) (10.9 ) Total non-interest expense 41,596 37,060 4,536 12.2 Income (loss) before income tax expense (11,479 ) 7,869 (19,348 ) (245.9 ) Income tax expense (benefit) (3,764 ) 1,973 (5,737 ) (290.8 ) Net income (loss) $ (7,715 ) $ 5,896 $ (13,611 ) (230.9 ) % Expand Assabet Valley Bancorp Average Balances and Average Yields And Costs (Unaudited) For the Quarters Ended June 30, 2025 March 31, 2025 June 30, 2024 (Dollars in thousands) Average Outstanding Balance Interest Average Yield/ Rate Average Outstanding Balance Interest Average Yield/Rate Average Outstanding Balance Interest Average Yield/ Rate Interest-earning assets: Short-term investments $ 67,357 $ 421 2.51 % $ 37,105 $ 215 2.35 % $ 49,032 $ 568 4.66 % Securities 296,321 2,555 3.46 309,608 2,651 3.47 352,204 2,833 3.24 Loans 2,229,893 28,883 5.20 2,214,952 28,183 5.16 2,015,649 27,492 5.49 Total interest-earning assets 2,593,571 31,859 4.93 2,561,665 31,049 4.92 2,416,885 30,893 5.14 Noninterest-earning assets 122,176 105,220 104,623 Total assets $ 2,715,747 $ 2,666,885 $ 2,521,508 Interest-bearing liabilities: NOW accounts $ 697,452 $ 700 0.40 % $ 690,014 $ 813 0.48 % $ 605,633 $ 737 0.49 % Money market accounts 270,969 848 1.26 260,430 842 1.31 299,203 1,117 1.50 Regular and other savings accounts 401,215 2,278 2.28 383,017 2,098 2.22 348,440 2,231 2.58 Certificates of deposit 347,419 3,416 3.94 387,556 3,978 4.16 246,367 4,200 6.86 Total interest-bearing deposits 1,717,055 7,242 1.69 1,721,017 7,731 1.82 1,499,643 8,285 2.22 FHLB advances and other borrowings (1) 333,834 3,647 4.38 339,814 3,792 4.53 362,083 3,985 4.43 Subordinated debt 27,782 352 5.08 27,691 315 4.61 27,592 315 4.59 Total interest-bearing liabilities 2,078,671 11,241 2.17 2,088,522 11,838 2.30 1,889,319 12,585 2.68 Noninterest-bearing demand deposits 415,035 336,000 388,359 Other noninterest-bearing liabilities 33,242 45,439 43,526 Total liabilities 2,526,948 2,469,961 2,321,203 Total capital 188,799 196,924 200,305 Total liabilities and capital $ 2,715,747 $ 2,666,885 $ 2,521,508 Net interest income $ 20,618 $ 19,211 $ 18,308 Net interest rate spread (2) 2.76 % 2.62 % 2.46 % Net interest-earning assets (3) $ 514,900 $ 473,143 $ 527,566 Net interest margin (4) 3.19 % 3.04 % 3.05 % Average interest-earning assets to interest-bearing liabilities 124.77 % 122.65 % 127.92 % (1) Average balances for borrowings includes the financing lease obligation which is presented under other liabilities on the consolidated balance sheet. (2) Net interest rate spread represents the difference between the weighted average yield on interest-earning assets and the weighted average rate of interest-bearing liabilities. (3) Net interest-earning assets represent total interest-earning assets less total interest-bearing liabilities. (4) Net interest margin represents net interest income divided by average total interest-earning assets. Expand


Hamilton Spectator
2 hours ago
- Hamilton Spectator
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in need, today announced equity inducement grants to six new non-officer employees consisting of an aggregate of 24,200 share options. All of the foregoing share options were approved by the Compensation Committee of the Company's Board of Directors with an effective date of July 31, 2025 and were granted as inducements material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The share options have an exercise price of $30.54 per common share, which is equal to the closing price per share of Xenon's common shares on the grant date of July 31, 2025. The share option grants vest over four years, with 25% vesting on the one-year anniversary of the respective employee's start date and 1/36th of the remaining options vesting monthly thereafter on the last day of each month, subject to such option recipient's continued service relationship with the Company. Each option has a 10-year term and is subject to the terms and conditions of the share option agreement and the terms of the Company's 2025 Inducement Equity Incentive Plan. About Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals (Nasdaq: XENE) is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics. We are advancing an ion channel product portfolio to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications. For more information, please visit . 'Xenon' and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner. Contacts: For Investors: Chad Fugere Vice President, Investor Relations (857) 675-7275 investors@ For Media: Colleen Alabiso Senior Vice President, Corporate Affairs (617) 671-9238 media@


Hamilton Spectator
2 hours ago
- Hamilton Spectator
Lumine Group Inc. Announces Results for the Three and Six Months Ended June 30, 2025
TORONTO, Aug. 01, 2025 (GLOBE NEWSWIRE) — Lumine Group Inc. ('Lumine Group' or 'the Company') (TSXV:LMN) announces financial results for the three and six months ended June 30, 2025. All amounts referred to in this press release are in US dollars unless otherwise stated. The following press release should be read in conjunction with the Company's unaudited condensed consolidated interim financial statements for the three and six months ended June 30, 2025, and management's discussion and analysis ('MD&A') for the three and six months ended June 30, 2025, which can be found on SEDAR+ at . Additional information about Lumine Group is also available on SEDAR+ and on Lumine Group's website . Q2 2025 Headlines: Year-to-Date Q2 2025 Headlines: Total revenue for the three months ended June 30, 2025 is $184.0 million, an increase of 13% or $21.1 million, compared to $162.8 million for the same period in 2024. For the six months ended June 30, 2025, total revenue was $362.6 million, an increase of 19%, or $58.7 million, compared to $303.9 million for the same period in 2024. The increase for the three and six months compared to the same period in the prior year is attributable to revenues from new acquisitions. The Company experienced organic growth of 9% and 2%, respectively, for the three and six months ended June 30, 2025, or 6% and 1% after adjusting for the impact of changes in the valuation of the US dollar against most major currencies in which the Company transacts business. For acquired companies, organic growth is calculated as the difference between actual revenues achieved by each business in the financial period following acquisition, compared to the estimated revenues they achieved in the corresponding financial period preceding the date of acquisition by the Company. Organic growth is not a standardized financial measure and might not be comparable to measures disclosed by other issuers. Operating income for the three months ended June 30, 2025 was $62.7 million, an increase of 71%, or $26.1 million, compared to $36.6 million for the same period in 2024. Operating income for the six months ended June 30, 2025 was $122.2 million, an increase of 51%, or $41.1 million, compared to $81.1 million for the same period in 2024. The increase for the three and six month periods is primarily attributable to growth from acquisitions. Operating income is not a standardized financial measure and might not be comparable to measures disclosed by other issuers. See 'Non-IFRS Measures'. Net income for the three months ended June 30, 2025 was $23.6 million compared to net loss of $2.2 million for the same period in 2024. Net income for the six months ended June 30, 2025 was $44.3 million compared to net loss of $306.6 million for the same period in 2024. The increase in net income for the three and six months is primarily attributable to growth from acquisitions and the Mandatory Conversion of Preferred and Special Securities on March 25, 2024 such that no further preferred and special securities expense was booked in the subsequent quarters. For the three months ended June 30, 2025, CFO increased $68.7 million to $78.4 million compared to $9.7 million for the same period in 2024 representing an increase of 705%. For the six months ended June 30, 2025, CFO increased $73.8 million to $118.5 million compared to $44.7 million for the same period in 2024 representing an increase of 165%. The primary reason for the increase is that CFO includes the impact of changes in non-cash operating assets and liabilities exclusive of effects of business combinations or changes in non-cash operating working capital ('NCOWC') which improved during the three and six months ended June 30, 2025 compared to the same period prior year, as well as higher operating income. For the three months ended June 30, 2025, FCFA2S increased $69.6 million to $72.4 million compared to $2.8 million for the same period in 2024. For the six months ended June 30, 2025, FCFA2S increased $75.8 million to $107.4 million compared to $31.5 million for the same period in 2024. The increase in the three and six months ended June 30, 2025 is driven by higher CFO compared to the same periods in 2024. FCFA2S is a non-IFRS Measure. See 'Non-IFRS Measures'. Non-IFRS Measures Operating income (loss) refers to income (loss) before income taxes, amortization of intangible assets, redeemable Preferred and Special Share expense, gain on bargain purchase, and finance and other expenses (income). We believe that operating income is useful supplemental information as it provides an indication of the profitability of the Company related to its core operations. Operating income (loss) is not a recognized measure under IFRS and may not be comparable to similar financial measures disclosed by other issuers. Accordingly, readers are cautioned that operating income (loss) should not be construed as an alternative to net income (loss). The following table reconciles operating income to net income: Free cash flow available to shareholders ''FCFA2S'' refers to net cash flows from operating activities less interest paid on lease obligations, interest paid on bank debt, transaction costs on bank debt, repayments of lease obligations, interest, dividends and other proceeds received, and property and equipment purchased net of proceeds from disposal. The Company believes that FCFA2S is useful supplemental information as it provides an indication of the uncommitted cash flow that is available to shareholders if Lumine Group does not make any acquisitions, or investments, and does not repay any debts. While the Company could use the FCFA2S to pay dividends or repurchase shares, the Company's objective is to invest all of its FCFA2S in acquisitions which meet the Company's hurdle rate. FCFA2S is not a recognized measure under IFRS and may not be comparable to similar financial measures disclosed by other issuers. Accordingly, readers are cautioned that FCFA2S should not be construed as an alternative to net cash flows from operating activities. The following table reconciles FCFA2S to net cash flows from operating activities: Forward Looking Statements Certain statements herein may be 'forward looking' statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Lumine Group or the industry to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to vary significantly from the results discussed in the forward looking statements. These forward looking statements reflect current assumptions and expectations regarding future events and operating performance and are made as of the date hereof and Lumine Group assumes no obligation, except as required by law, to update any forward looking statements to reflect new events or circumstances. About Lumine Group Inc. Lumine Group acquires, strengthens, and grows, vertical market software businesses in the communications and media industry. Learn more at . For further information: David Nyland Chief Executive Officer Lumine Group investors@ +1-437-353-4910 Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Condensed Consolidated Interim Statements of Financial Position (In thousands of USD. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statements of Income (Loss) (In thousands of USD, except per share amounts. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statements of Comprehensive Income (Loss) (In thousands of USD. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statement of Changes in Equity (In thousands of USD. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statement of Changes in Equity (In thousands of USD. Due to rounding, numbers presented may not foot.) Condensed Consolidated Interim Statements of Cash Flows (In thousands of USD. Due to rounding, numbers presented may not foot.) 1 See 'Non-IFRS Measures'.